Literature DB >> 18712412

Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouse.

Kristen A Baltgalvis1, Franklin G Berger, Maria Marjorette O Peña, J Mark Davis, James P White, James A Carson.   

Abstract

Interleukin-6 (IL-6) is necessary for cachexia in Apc ( Min/+ ) mice, but the mechanisms inducing this myofiber wasting have not been established. The purpose of this study was to examine gastrocnemius muscle wasting in the Apc ( Min/+ ) mouse and to determine IL-6 regulated mechanisms contributing to muscle loss. Gastrocnemius type IIB mean fiber cross-sectional area (CSA) from Apc ( Min/+ ) mice decreased 32% between 13 and 22 weeks of age. Apc ( Min/+ ) mice lacking IL-6 did not have type IIB fiber atrophy, while overexpression of circulating IL-6 exacerbated the loss of type IIB fiber CSA in Apc ( Min/+ ) mice. Muscle Atrogin-I mRNA expression was induced at least ninefold at 18 and 22 weeks of age compared to 13-week-old mice. Atrogin-I gene expression was also induced by overexpression of circulating IL-6. These data suggest that high circulating IL-6 levels induce type IIB fiber CSA loss in Apc ( Min/+ ) mice, and circulating IL-6 is sufficient to regulate Atrogin-I gene expression in cachectic mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18712412      PMCID: PMC2867110          DOI: 10.1007/s00424-008-0574-6

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  55 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Role of ubiquitin-proteasome-dependent proteolytic process in degradation of muscle protein from diabetic rabbits.

Authors:  V D Galban; E A Evangelista; R H Migliorini; I do Carmo Kettelhut
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

3.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy.

Authors:  M D Gomes; S H Lecker; R T Jagoe; A Navon; A L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

4.  Interleukin-6-deficient mice develop mature-onset obesity.

Authors:  Ville Wallenius; Kristina Wallenius; Bo Ahrén; Mats Rudling; Hans Carlsten; Suzanne L Dickson; Claes Ohlsson; John-Olov Jansson
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

5.  Identification of ubiquitin ligases required for skeletal muscle atrophy.

Authors:  S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

6.  Mutation of the IIB myosin heavy chain gene results in muscle fiber loss and compensatory hypertrophy.

Authors:  D L Allen; B C Harrison; C Sartorius; W C Byrnes; L A Leinwand
Journal:  Am J Physiol Cell Physiol       Date:  2001-03       Impact factor: 4.249

7.  The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.

Authors:  Jun-ichi Hanai; Peirang Cao; Preeti Tanksale; Shintaro Imamura; Eriko Koshimizu; Jinghui Zhao; Shuji Kishi; Michiaki Yamashita; Paul S Phillips; Vikas P Sukhatme; Stewart H Lecker
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

8.  Cancer cachexia is regulated by selective targeting of skeletal muscle gene products.

Authors:  Swarnali Acharyya; Katherine J Ladner; Lori L Nelsen; Jeffrey Damrauer; Peter J Reiser; Steven Swoap; Denis C Guttridge
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

9.  Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres.

Authors:  Jiandie Lin; Hai Wu; Paul T Tarr; Chen-Yu Zhang; Zhidan Wu; Olivier Boss; Laura F Michael; Pere Puigserver; Eiji Isotani; Eric N Olson; Bradford B Lowell; Rhonda Bassel-Duby; Bruce M Spiegelman
Journal:  Nature       Date:  2002-08-15       Impact factor: 49.962

10.  Interleukin-6 and cachexia in ApcMin/+ mice.

Authors:  Kristen A Baltgalvis; Franklin G Berger; Maria Marjorette O Pena; J Mark Davis; Stephanie J Muga; James A Carson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-12-05       Impact factor: 3.619

View more
  63 in total

1.  Rel A/p65 is required for cytokine-induced myotube atrophy.

Authors:  Takuo Yamaki; Chia-Ling Wu; Michael Gustin; Jamie Lim; Robert W Jackman; Susan C Kandarian
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-16       Impact factor: 4.249

Review 2.  Interleukin 6 as a key regulator of muscle mass during cachexia.

Authors:  James A Carson; Kristen A Baltgalvis
Journal:  Exerc Sport Sci Rev       Date:  2010-10       Impact factor: 6.230

3.  Creatine supplementation in Walker-256 tumor-bearing rats prevents skeletal muscle atrophy by attenuating systemic inflammation and protein degradation signaling.

Authors:  Paola S Cella; Poliana C Marinello; Fernando H Borges; Diogo F Ribeiro; Patrícia Chimin; Mayra T J Testa; Philippe B Guirro; José A Duarte; Rubens Cecchini; Flávia A Guarnier; Rafael Deminice
Journal:  Eur J Nutr       Date:  2019-02-26       Impact factor: 5.614

4.  A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice.

Authors:  Wai W Cheung; Wei Ding; Sujana S Gunta; Yong Gu; Rinat Tabakman; Leah N Klapper; Arieh Gertler; Robert H Mak
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

5.  Influenza A Virus Infection Induces Muscle Wasting via IL-6 Regulation of the E3 Ubiquitin Ligase Atrogin-1.

Authors:  Kathryn A Radigan; Trevor T Nicholson; Lynn C Welch; Monica Chi; Luciano Amarelle; Martín Angulo; Masahiko Shigemura; Atsuko Shigemura; Constance E Runyan; Luisa Morales-Nebreda; Harris Perlman; Ermelinda Ceco; Emilia Lecuona; Laura A Dada; Alexander V Misharin; Gokhan M Mutlu; Jacob I Sznajder; G R Scott Budinger
Journal:  J Immunol       Date:  2018-12-07       Impact factor: 5.422

Review 6.  Cancer cachexia, mechanism and treatment.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Hisahiro Matsubara; Kazuaki Takabe
Journal:  World J Gastrointest Oncol       Date:  2015-04-15

7.  Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: application to analysis of murine muscles during cancer cachexia.

Authors:  Maria Lima; Shuichi Sato; Reilly T Enos; John W Baynes; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2013-01-17

8.  Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.

Authors:  James P White; Melissa J Puppa; Song Gao; Shuichi Sato; Stephen L Welle; James A Carson
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-26       Impact factor: 4.310

Review 9.  Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle.

Authors:  Mark Romanick; Ladora V Thompson; Holly M Brown-Borg
Journal:  Biochim Biophys Acta       Date:  2013-03-20

10.  Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humans.

Authors:  Edward K Merritt; Michael J Stec; Anna Thalacker-Mercer; Samuel T Windham; James M Cross; David P Shelley; S Craig Tuggle; David J Kosek; Jeong-Su Kim; Marcas M Bamman
Journal:  J Appl Physiol (1985)       Date:  2013-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.